1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-04-28
3 classes of this one portfolio · 0 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000092484 | AEDFX | NOT_LISTED | not exchange-listed | — |
| C000092485 | AEDNX | NOT_LISTED | not exchange-listed | — |
| C000127229 | AGEAX | NOT_LISTED | not exchange-listed | — |
as filed
N-PORT Item C.4.b
N-PORT Item C.4.a
149 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| Dick's Sporting Goods Inc | DKS | 253393102 US2533931026 | EC CORP | 1,250 NS | $254.5K | 0.508% | US |
| Ventyx Biosciences Inc | — | 92332V107 US92332V1070 | EC CORP | 18,076 NS | $252.5K | 0.504% | US |
| Alexander & Baldwin Inc | — | 014491104 US0144911049 | EC OTHER | 11,826 NS | $245.9K | 0.490% | US |
| CONTRA RESOLUTE FOREST | — | 761CVR042 US761CVR0427 | DE OTHER | 68,936 NS | $102.5K | 0.205% | US |
| CONTRA ALBIREO PHARMA | — | 013CVR022 — | DE OTHER | 34,047 NS | $97.3K | 0.194% | US |
| Bristol-Myers Squibb Co | — | 110122157 US1101221570 | DE OTHER | 67,803 NS | $76.3K | 0.152% | US |
| CONTRA CONCERT PHARMAC | — | 206CVR011 — | DE OTHER | 154,954 NS | $76.1K | 0.152% | US |
| Figma Inc | FIG | 316841105 US3168411052 | EC CORP | 1,600 NS | $47.0K | 0.094% | US |
| CONTRA METSERA INC | — | 592CVR013 — | DE OTHER | 8,653 NS | $43.6K | 0.087% | US |
| CONTRA AVADEL PHARMACE | — | 000000000 — | DE OTHER | 35,059 NS | $22.5K | 0.045% | IE |
| CONTRA ABIOMED INC | — | 003CVR016 US003CVR0169 | DE OTHER | 13,890 NS | $22.2K | 0.044% | US |
| Atrium Therapeutics Inc | RNA | 04965N104 US04965N1046 | EC CORP | 1,150 NS | $17.0K | 0.034% | US |
| Morgan Stanley & Co. LLC ELECTRONIC ARTS INC | — | 000000000 — | DE OTHER | 32 NC | $15.7K | 0.031% | US |
| CONTRA AKERO THERAPEUT | — | 009CVR044 — | DE OTHER | 16,553 NS | $11.0K | 0.022% | US |
| CONTRA TREEHOUSE FOODS | — | 894CVR018 — | DE OTHER | 5,664 NS | $11.0K | 0.022% | US |
| Goldman Sachs & Co. LLC ZIM INTEGRATED SHIPPING SERVIC | — | 000000000 — | DE OTHER | 172 NC | $6.2K | 0.012% | IL |
| RAPT Therapeutics Inc | — | 75382E208 US75382E2081 | EC CORP | 100 NS | $5.8K | 0.012% | US |
| Morgan Stanley & Co. LLC BANCO SANTANDER SA | — | 000000000 — | DE OTHER | 71 NC | $5.0K | 0.010% | ES |
| Goldman Sachs & Co. LLC SILICON LABORATORIES INC | — | 000000000 — | DE OTHER | 24 NC | $4.6K | 0.009% | US |
| Stellar Bancorp Inc | — | 858927106 US8589271068 | EC CORP | 121 NS | $4.6K | 0.009% | US |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD GBP | — | 000000000 — | DFE OTHER | 1 NC | $4.2K GBP | 0.008% | US |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD GBP | — | 000000000 — | DFE OTHER | 1 NC | $3.9K GBP | 0.008% | US |
| Morgan Stanley & Co. LLC WARNER BROS DISCOVERY INC | — | 000000000 — | DE OTHER | 516 NC | $3.6K | 0.007% | US |
| Morgan Stanley & Co. LLC KENVUE INC | — | 000000000 — | DE OTHER | 335 NC | $3.4K | 0.007% | US |
| Morgan Stanley & Co. LLC BANCO SANTANDER SA | — | 000000000 — | DE OTHER | 71 NC | $3.2K | 0.006% | ES |
| Morgan Stanley & Co. LLC CLEARWATER ANALYTICS HOLDINGS | — | 000000000 — | DE OTHER | 114 NC | $2.3K | 0.005% | US |
| Morgan Stanley & Co. LLC PURCHASED EUR / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $2.1K EUR | 0.004% | XX |
| Morgan Stanley & Co. LLC KENVUE INC | — | 000000000 — | DE OTHER | 36 NC | $1.4K | 0.003% | US |
| Goldman Sachs & Co. LLC KENVUE INC | — | 000000000 — | DE OTHER | 66 NC | $1.2K | 0.002% | US |
| Morgan Stanley & Co. LLC PURCHASED GBP / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $940.10 GBP | 0.002% | GB |
| Morgan Stanley & Co. LLC CLEARWATER ANALYTICS HOLDINGS | — | 000000000 — | DE OTHER | 37 NC | $925.00 | 0.002% | US |
| Morgan Stanley & Co. LLC ELECTRONIC ARTS INC | — | 000000000 — | DE OTHER | 7 NC | $805.00 | 0.002% | US |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD CAD | — | 000000000 — | DFE OTHER | 1 NC | $528.27 CAD | 0.001% | US |
| Morgan Stanley & Co. LLC KENVUE INC | — | 000000000 — | DE OTHER | 36 NC | $252.00 | 0.001% | US |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD EUR | — | 000000000 — | DFE OTHER | 1 NC | $236.32 EUR | 0.000% | US |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $234.93 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $223.55 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $170.50 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $137.53 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED EUR / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $132.46 EUR | 0.000% | XX |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $110.26 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD CAD | — | 000000000 — | DFE OTHER | 1 NC | $98.36 CAD | 0.000% | US |
| Morgan Stanley & Co. LLC PURCHASED EUR / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $79.12 EUR | 0.000% | XX |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD EUR | — | 000000000 — | DFE OTHER | 1 NC | $70.53 EUR | 0.000% | US |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $60.91 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED USD / SOLD EUR | — | 000000000 — | DFE OTHER | 1 NC | $56.40 EUR | 0.000% | US |
| Palo Alto Networks Inc | PANW | 697435105 US6974351057 | EC CORP | 0.29 NS | $42.74 | 0.000% | US |
| Morgan Stanley & Co. LLC PURCHASED EUR / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $41.55 EUR | 0.000% | XX |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $36.60 CAD | 0.000% | CA |
| Morgan Stanley & Co. LLC PURCHASED CAD / SOLD USD | — | 000000000 — | DFE OTHER | 1 NC | $34.40 CAD | 0.000% | CA |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 22.0% of reported value reaches a classification.
Percentages are of the reported value of positions above ($48.86M), not of the fund’s net assets ($50.13M). The two differ by cash, derivatives filed with no market value, and rounding.